Anthony Petrone

Mizuho | Healthcare

Anthony Petrone is an analyst from Mizuho specializing in the Healthcare sector. Ranked #1436 out of 4643 analysts, they have issued 59 stock ratings with a success rate of 95.11% and an average return of 9.90%.

Anthony Petrone has a well-established track record, with 59 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 95.11% and an average return of 9.90%, underscoring their expertise and ability to identify winning opportunities for investors.

#1436

Out of 4643

59

Total Ratings

+95.11%

Success Rate

+9.90%

Average Return

Recent Ratings Analysis

MNKD

May 07, 2026

Target

$7.00

Current

$3.52

Performance

-0.85%

Anthony Petrone rated MNKD as Outperform on May 07, 2026, setting a price target of 7. Shares have remained stable near 3.52, leaving the 7 target still in play.

LIVN

May 07, 2026

Target

$90.00

Current

$71.86

Performance

1.31%

On May 07, 2026, LIVN was given a Outperform rating by Anthony Petrone, with a target price of 90. The stock traded sideways with a 1.31% move, keeping the bullish thesis unresolved.

ALC

May 07, 2026

Target

$85.00

Current

$62.56

Performance

-2.07%

ALC received a Outperform rating from Anthony Petrone on May 07, 2026, aiming for 85. Price action was muted, as shares hovered around 62.56 despite the bullish outlook.

ADMA

May 07, 2026

Target

$20.00

Current

$8.17

Performance

-3.54%

On May 07, 2026, Anthony Petrone published a Outperform outlook on ADMA, with a target of 20. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 8.17.

EMBC

May 06, 2026

Target

$5.00

Current

$3.64

Performance

2.25%

Anthony Petrone on May 06, 2026 assigned EMBC a Neutral rating, with a price target of 5. The Hold stance reflected consolidation, as shares held near 3.64.

INSP

May 05, 2026

Target

$55.00

Current

$44.26

Performance

-8.27%

On May 05, 2026, Anthony Petrone reaffirmed INSP with a Outperform rating, targeting 55. Shares slid 8.27% despite the recommendation, highlighting downside risks.

EW

Apr 13, 2026

Target

$95.00

Current

$79.96

Performance

2.36%

EW was rated Outperform by Anthony Petrone on Apr 13, 2026, with a price objective of 95. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

BSX

Apr 13, 2026

Target

$90.00

Current

$53.93

Performance

-14.64%

On Apr 13, 2026, Anthony Petrone initiated coverage on BSX with a Outperform rating and target of 90. The Buy call has yet to be validated as shares remain 36.07 away from the target.

MDT

Apr 13, 2026

Target

$120.00

Current

$76.15

Performance

-13.47%

Anthony Petrone issued a Outperform recommendation for MDT on Apr 13, 2026, price target set at 120. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

LNTH

Apr 13, 2026

Target

$95.00

Current

$93.06

Performance

13.95%

On Apr 13, 2026, LNTH was evaluated by Anthony Petrone, who gave a Outperform rating and target of 95. This case illustrates how a timely bullish rating can translate into tangible gains of 13.95%.

ISRG

Apr 13, 2026

Target

$525.00

Current

$450.06

Performance

-1.94%

Anthony Petrone rated ISRG as Neutral on Apr 13, 2026, setting a price target of 525. The Hold stance appears justified, as shares hovered around 450.06 with a -1.94% move.

HAE

Apr 13, 2026

Target

$70.00

Current

$55.12

Performance

-7.00%

On Apr 13, 2026, HAE was given a Outperform rating by Anthony Petrone, with a target price of 70. Despite the Buy call, shares fell from 55.12 to 55.12, challenging the optimistic stance.

GEHC

Apr 13, 2026

Target

$90.00

Current

$63.47

Performance

-14.03%

GEHC received a Outperform rating from Anthony Petrone on Apr 13, 2026, aiming for 90. The rating hasn’t played out as hoped, with the stock trading 14.03% below expectations.

MMED

Mar 31, 2026

Target

$21.00

Current

$11.57

Performance

-22.45%

On Mar 31, 2026, Anthony Petrone published a Outperform outlook on MMED, with a target of 21. Market action contradicted the Buy thesis, as shares slipped to 11.57.

ESTA

Feb 25, 2026

Target

$100.00

Current

$71.77

Performance

-8.33%

Anthony Petrone on Feb 25, 2026 assigned ESTA a Outperform rating, with a price target of 100. The call has struggled to gain traction, with shares losing 8.33%.

TNDM

Feb 20, 2026

Target

$22.00

Current

$15.48

Performance

-37.00%

On Feb 20, 2026, Anthony Petrone reaffirmed TNDM with a Neutral rating, targeting 22. The Hold stance reflected market caution that was later justified.

DXCM

Feb 13, 2026

Target

$90.00

Current

$60.61

Performance

-13.44%

DXCM was rated Outperform by Anthony Petrone on Feb 13, 2026, with a price objective of 90. This case shows how bullish projections can fail, with the stock now below 60.61.

EXAS

Jan 20, 2026

Target

$105.00

Current

$104.91

Performance

2.50%

On Jan 20, 2026, Anthony Petrone initiated coverage on EXAS with a Neutral rating and target of 105. The stock’s lack of movement around 104.91 aligned with a cautious approach.

MDXG

Dec 17, 2025

Target

$12.00

Current

$3.60

Performance

-49.22%

Anthony Petrone issued a Outperform recommendation for MDXG on Dec 17, 2025, price target set at 12. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

GH

Dec 17, 2025

Target

$120.00

Current

$95.70

Performance

-1.82%

On Dec 17, 2025, GH was evaluated by Anthony Petrone, who gave a Outperform rating and target of 120. So far, the Buy call awaits clearer momentum, with shares flat at 95.7.

COO

Dec 05, 2025

Target

$100.00

Current

$60.00

Performance

-26.29%

Anthony Petrone rated COO as Outperform on Dec 05, 2025, setting a price target of 100. The stock has underperformed, dropping 26.29% despite the bullish target of 100.

AXGN

Dec 01, 2025

Target

$40.00

Current

$42.06

Performance

47.42%

On Dec 01, 2025, AXGN was given a Outperform rating by Anthony Petrone, with a target price of 40. The stock rallied 47.42% after the rating, narrowing the gap to the target of 40 and validating the bullish stance.

RMD

Oct 31, 2025

Target

$300.00

Current

$206.76

Performance

-16.25%

RMD received a Outperform rating from Anthony Petrone on Oct 31, 2025, aiming for 300. The rating hasn’t played out as hoped, with the stock trading 16.25% below expectations.

HOLX

Oct 23, 2025

Target

$78.00

Current

$76.01

Performance

2.87%

On Oct 23, 2025, Anthony Petrone published a Neutral outlook on HOLX, with a target of 78. Sideways action left the Hold view intact, with no major move since 76.01.

TFX

Aug 01, 2025

Target

$135.00

Current

$133.06

Performance

14.82%

Anthony Petrone on Aug 01, 2025 assigned TFX a Neutral rating, with a price target of 135. Shares outperformed expectations, climbing 14.82% despite the neutral view.

ABT

Jul 18, 2025

Target

$135.00

Current

$84.30

Performance

-31.83%

On Jul 18, 2025, Anthony Petrone reaffirmed ABT with a Neutral rating, targeting 135. The Hold stance reflected market caution that was later justified.

STAA

Jul 16, 2025

Target

$18.00

Current

$26.69

Performance

56.17%

STAA was rated Neutral by Anthony Petrone on Jul 16, 2025, with a price objective of 18. Despite caution, upside momentum rewarded risk-takers with gains to 26.69.

GKOS

Apr 16, 2025

Target

$175.00

Current

$133.52

Performance

50.36%

On Apr 16, 2025, Anthony Petrone initiated coverage on GKOS with a Outperform rating and target of 175. The stock’s climb of 50.36% since the call highlights the foresight in the rating.

SENS

Apr 10, 2025

Target

$2.00

Current

$5.03

Performance

-55.95%

Anthony Petrone issued a Outperform recommendation for SENS on Apr 10, 2025, price target set at 2. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

TARS

Mar 06, 2025

Target

$58.00

Current

$61.21

Performance

40.49%

On Mar 06, 2025, TARS was evaluated by Anthony Petrone, who gave a Buy rating and target of 58. This case illustrates how a timely bullish rating can translate into tangible gains of 40.49%.

Frequency Asked Questions

Who is Anthony Petrone?

Anthony Petrone is an analyst from Mizuho specializing in the Healthcare sector.

What is Anthony Petrone's success rate?

Anthony Petrone currently has a success rate of +95.11%.

How many ratings has Anthony Petrone issued?

Anthony Petrone has issued 59 stock ratings so far.

What is the average return of Anthony Petrone's calls?

Their stock ratings have generated an average return of +9.90%.

What is Anthony Petrone's ranking?

Anthony Petrone is ranked #1436 out of 4643 analysts.

What types of ratings does Anthony Petrone give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Anthony Petrone?

You can follow Anthony Petrone by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Anthony Petrone?

Their latest rating was a Buy on MNKD issued on 2026-05-07.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep